Is the psychedelic industry the new cannabis for investing and wall street? Sad but true

We're here to provide higher-risk industries with e-commerce and retail debit and credit card merchant payment processing when others won't.

https://www.qannasolutions.com/


Watch the full video about psychedelics on Yahoo! 

Image of Video on Yahoo



Link is posted below.

Short clip of full video



Keep your thumb on the pulse of what's going on with the stock market, and the psychedelic industry right now.


Did you know that Kevin O'Leary from the TV show Shark Tank has invested in MindMed? 

https://mindmed.co/


Mental health  treatment may be the next biggest, necessary, and unfortunate industry in the United States. This will include training the new generation of psychologist to administer these newly available treatments. 

Watch the video for more great information about psychedelics and the medical industry.  


This blog is to alert investors to what is going on, and to inform people in the psychedelic industry that Qanna Solutions offers a solution for high-risk merchant payment processing.


As new rules and regulations begin to emerge in mainstream discussions, many people are positioning themselves to gain big in the psychedelic industry.


But first, a few things we should know about the similarities and differences of the cannabis industry vs. the psychedelic industry.


Contact a trusted attorney or licensed advisor for all legal questions and inquiries.


A few key discussions to consider:

1. Banking for psychedelics


2. High-risk merchant accounts


3. Various sub-industries that will serve along side of psychedelics


4. Are psychedelic drugs a viable choice for medical treatments?


5. LSD and magic mushrooms approved by FDA?


. . . . just a few things up for discussion.


Reference:

Yahoo Finance 

FULL VIDEO HERE

https://finance.yahoo.com/news/wall-street-eyes-mental-health-as-the-next-great-growth-story-132619645.html

FULL VIDEO HERE


Quote from video clip

"Unlike the cannabis industry, Rahn said psychedelic biotech firms are not seeking state-by-state approvals for their pipeline of drugs. “Companies that are taking this biotech approach are really looking at proving out the safety and efficacy of these medicines at the FDA."

abis' for investorsThe psycWe're here to provide higher-risk industries with e-commerce and retail debit and credit card merchant payment processing when others won't.

https://www.qannasolutions.com/

(800) 385-6201 




Subscribe to our channel please.

#qannasolutionsnewsalert 

Comments

Popular posts from this blog

Compare all best solutions for cannabis dispensary credit card payment processing

Cannabis industry CPA, lawyer, consultant, and dispensary owners need this service

Financial responsibility is a big part of creating more financially literate communities